3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
6
Neoplasm Metastasis
3
Lung Neoplasms
3
Stomatitis
2
Recurrence
2
Nasopharyngeal Carcinoma
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Vitamin B 12 Deficiency
1
Urinary Bladder Neoplasms
1
Thyroid Diseases
1
Stomach Neoplasms
1
Smoking
1
Prostatic Neoplasms
1
Peripheral Nervous System Diseases
1
Oligodendroglioma
1
Nasopharyngeal Neoplasms
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, B-Cell
1
Laryngeal Diseases
1
Gliosarcoma
1
Glioblastoma
1
Central Nervous System Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma
1
Brain Edema
1
Astrocytoma
1
Interventions
Glutamine
2
sagopilone
1
nicotinamide-beta-riboside
1
allantoicase
1
Vitamin D
1
Vitamin B 6
1
Vitamin B 12
1
Taxoids
1
Tadalafil
1
Sirolimus
1
Prednisolone
1
Paclitaxel
1
Minocycline
1
Metformin
1
Losartan
1
Hydroxychloroquine
1
G(M1) Ganglioside
1
Fatty Acids, Omega-3
1
Exercise
1
Everolimus
1
Etoricoxib
1
Ethosuximide
1
Epoetin Alfa
1
Dietary Supplements
1
Dexamethasone
1
Cryotherapy
1
Bortezomib
1
BID protein, human
1
Acupuncture Therapy
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Peripheral Nervous System Diseases
×
Vitamin B 12
×
Clear all
NCT02795572
2019-07-05
CIPN
AHS Cancer Control Alberta
Phase 2
Terminated
13 enrolled